EXPIRED
March 4, 2022
PA-21-071 - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
Office of The Director, National Institutes of Health (OD)
The purpose of this Notice of Interest (NOSI) is to encourage eligible grantees to apply for this administrative supplement aimed at fostering diversity in the child health research workforce in the Environmental influences on Child Health Outcomes (ECHO) - Institutional Development Awards (IDeA) States Pediatric Clinical Trials Network (ISPCTN) Program.
The ECHO Program’s mission is to enhance the health of children for generations to come. The ECHO-ISPCTN helps address disparities in pediatric research by including children from rural or underserved populations in clinical trials, and by building pediatric research capacity in states with historically low NIH funding.
Research Topics: Applications must: 1) address the mission of ECHO, and 2) contribute to at least one of the completed, ongoing, or planned ISPCTN clinical trials. The appropriate research topics could include, but are not limited to, assisting a site PD/PI with conducting an ongoing ISPCTN clinical trial; secondary analyses of data resulting from ongoing or completed ISPCTN trials; or qualitative and quantitative studies designed to derive data supporting current or future trials in IDeA States (e.g., factors affecting rates of enrollment and retention at different clinical research sites; or factors influencing the accuracy of the data extracted from research records).
Eligibility: Diversity supplement candidate eligibility requirements are as listed in the PA-21-071, Research Supplements to Promote Diversity in Health-Related Research (Admin Supp-Clinical Trial Not Allowed). Individuals in Training programs in any of the medical, nursing, or allied health topics fields can apply.
Principal Investigators from ECHO-ISPCTN Clinical Site awards and the Data Coordinating and Operations Center (DCOC) can apply through the parent grant, under the stipulations in
PA 21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp-Clinical Trail Not Allowed). Applications for the Supplement can propose one candidate per award.
Review Criteria: The ECHO Program Office will determine the merits of applications based on evaluation of the following three equally weighted criteria :
Application and Submission Information
pplication due date: May 23, 2022
The Authorized Organizational Representative from your institution must submit all applications electronically to the NIH following the instructions in the Funding Opportunity Announcement (FOA):
PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp-Clinical Trial Not Allowed)
Additional details are available in the Frequently Asked Questions (FAQs) file; the agency contact noted below, will provide the link to the FAQs file.
All instructions in the SF424 (R&R) Application Guide and the listed funding opportunity announcements must be followed, with the following additions:
For funding consideration, applicants must include "NOT-OD-22-077" (without quotation marks) in the Agency Routing identifier field (Box 4B) of the SF 424 (R&R) Form. Applications without this information in box 4B will not be considered for this initiative.
The ECHO Program Office will not consider applications that fail to meet the terms of this Notice.
To facilitate efficient processing of the request, the ECHO Program Office strongly encourages applicants to consult the PO (the agency contact) noted below while preparing the application and to inform the PO after they have submitted the application in response to this NOSI.
Tonse Raju,MD (ISPCTN)
Email: [email protected]
Mobile: 202-302-3984
Environmental influences on Child Health Outcomes (ECHO) Office
NIH Office of the Director
Three White Flint North,
11601 Landsdown Street
North Bethesda, MD 20852